BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, Satoh S, Yamaguchi T, Imamura H, Inoue M, Shiozaki H. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene. 2004;23:6830-6844. [PMID: 15273739 DOI: 10.1038/sj.onc.1207886] [Cited by in Crossref: 83] [Cited by in F6Publishing: 79] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Zhu WG, Xu X. Ubiquitin-like modifications in the DNA damage response. Mutat Res 2017;803-805:56-75. [PMID: 28734548 DOI: 10.1016/j.mrfmmm.2017.07.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 5.6] [Reference Citation Analysis]
2 Takeno A, Takemasa I, Doki Y, Yamasaki M, Miyata H, Takiguchi S, Fujiwara Y, Matsubara K, Monden M. Integrative approach for differentially overexpressed genes in gastric cancer by combining large-scale gene expression profiling and network analysis. Br J Cancer 2008;99:1307-15. [PMID: 18827816 DOI: 10.1038/sj.bjc.6604682] [Cited by in Crossref: 62] [Cited by in F6Publishing: 55] [Article Influence: 4.4] [Reference Citation Analysis]
3 Chen CD, Wang CS, Huang YH, Chien KY, Liang Y, Chen WJ, Lin KH. Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics. 2007;7:155-167. [PMID: 17154271 DOI: 10.1002/pmic.200600663] [Cited by in Crossref: 81] [Cited by in F6Publishing: 79] [Article Influence: 5.4] [Reference Citation Analysis]
4 Rohwer N, Bindel F, Grimm C, Lin SJ, Wappler J, Klinger B, Blüthgen N, Du Bois I, Schmeck B, Lehrach H, de Graauw M, Goncalves E, Saez-Rodriguez J, Tan P, Grabsch HI, Prigione A, Kempa S, Cramer T. Annexin A1 sustains tumor metabolism and cellular proliferation upon stable loss of HIF1A. Oncotarget 2016;7:6693-710. [PMID: 26760764 DOI: 10.18632/oncotarget.6793] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Pandi NS, Suganya S, Rajendran S. In silico analysis of stomach lineage specific gene set expression pattern in gastric cancer. Biochemical and Biophysical Research Communications 2013;439:539-46. [DOI: 10.1016/j.bbrc.2013.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Vecchi M, Nuciforo P, Romagnoli S, Confalonieri S, Pellegrini C, Serio G, Quarto M, Capra M, Roviaro GC, Contessini Avesani E. Gene expression analysis of early and advanced gastric cancers. Oncogene. 2007;26:4284-4294. [PMID: 17297478 DOI: 10.1038/sj.onc.1210208] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 3.8] [Reference Citation Analysis]
7 Jang M, Koh I, Lee SJ, Cheong JH, Kim P. Droplet-based microtumor model to assess cell-ECM interactions and drug resistance of gastric cancer cells. Sci Rep 2017;7:41541. [PMID: 28128310 DOI: 10.1038/srep41541] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 5.2] [Reference Citation Analysis]
8 Cao B, Zhao Y, Zhang Z, Li H, Xing J, Guo S, Qiu X, Zhang S, Min L, Zhu S. Gene regulatory network construction identified NFYA as a diffuse subtype-specific prognostic factor in gastric cancer. Int J Oncol 2018;53:1857-68. [PMID: 30106137 DOI: 10.3892/ijo.2018.4519] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
9 Han HG, Moon HW, Jeon YJ. ISG15 in cancer: Beyond ubiquitin-like protein. Cancer Letters 2018;438:52-62. [DOI: 10.1016/j.canlet.2018.09.007] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
10 Junnila S, Kokkola A, Mizuguchi T, Hirata K, Karjalainen-Lindsberg ML, Puolakkainen P, Monni O. Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer. 2010;49:28-39. [PMID: 19780053 DOI: 10.1002/gcc.20715] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 4.8] [Reference Citation Analysis]
11 van der Kaaij RT, Koemans WJ, van Putten M, Snaebjornsson P, Luijten JCHBM, van Dieren JM, Cats A, Lemmens VEPP, Verhoeven RHA, van Sandick JW. A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015. Eur J Cancer 2020;130:23-31. [PMID: 32171106 DOI: 10.1016/j.ejca.2020.02.017] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
12 Wu SR, Wu Q, Shi YQ. Recent advances of miRNAs in the development and clinical application of gastric cancer. Chin Med J (Engl) 2020;133:1856-67. [PMID: 32649523 DOI: 10.1097/CM9.0000000000000921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
13 Cao J, Gong J, Li X, Hu Z, Xu Y, Shi H, Li D, Liu G, Jie Y, Hu B, Chong Y. Unsupervised Hierarchical Clustering Identifies Immune Gene Subtypes in Gastric Cancer. Front Pharmacol 2021;12:692454. [PMID: 34248641 DOI: 10.3389/fphar.2021.692454] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Bodey B, Bodey B Jr, Siegel SE. Mechanisms and markers of carcinogenesis and neoplastic progression. Expert Opin Biol Ther 2005;5:1317-32. [PMID: 16197337 DOI: 10.1517/14712598.5.10.1317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
15 Jaiswal RK, Kumar P, Kumar M, Yadava PK. hTERT promotes tumor progression by enhancing TSPAN13 expression in osteosarcoma cells. Mol Carcinog 2018;57:1038-54. [PMID: 29722072 DOI: 10.1002/mc.22824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wang SY, Shen XY, Wu CY, Pan F, Shen YY, Sheng HH, Chen XM, Gao HJ. Analysis of whole genomic expression profiles of Helicobacter pylori related chronic atrophic gastritis with IL-1B-31CC/-511TT genotypes. J Dig Dis 2009;10:99-106. [PMID: 19426391 DOI: 10.1111/j.1751-2980.2009.00367.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
17 Nam KH, Kim MA, Choe G, Kim WH, Lee HS. Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression. Gastric Cancer 2014;17:610-20. [PMID: 24337435 DOI: 10.1007/s10120-013-0324-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
18 Zhang F, Maswikiti EP, Wei Y, Wu W, Li Y. Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer. Dis Markers 2021;2021:5567392. [PMID: 34422135 DOI: 10.1155/2021/5567392] [Reference Citation Analysis]
19 Raso MC, Djoric N, Walser F, Hess S, Schmid FM, Burger S, Knobeloch KP, Penengo L. Interferon-stimulated gene 15 accelerates replication fork progression inducing chromosomal breakage. J Cell Biol 2020;219:e202002175. [PMID: 32597933 DOI: 10.1083/jcb.202002175] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
20 House MG, Brennan MF. Neoadjuvant therapy for gastric cancer. Adv Surg. 2008;42:151-168. [PMID: 18953815 DOI: 10.1016/j.yasu.2008.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
21 Capoccia BJ, Huh WJ, Mills JC. How form follows functional genomics: gene expression profiling gastric epithelial cells with a particular discourse on the parietal cell. Physiol Genomics 2009;37:67-78. [PMID: 19208773 DOI: 10.1152/physiolgenomics.90408.2008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
22 Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, Kiviluoto T, Karjalainen-Lindsberg ML, Hollmén J, Knuutila S, Puolakkainen P. Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer. 2008;123:817-825. [PMID: 18506690 DOI: 10.1002/ijc.23574] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
23 Cheng SX, Tu Y, Zhang S. FoxM1 promotes glioma cells progression by up-regulating Anxa1 expression. PLoS One 2013;8:e72376. [PMID: 23991102 DOI: 10.1371/journal.pone.0072376] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
24 Huang J, Ji EH, Zhao X, Cui L, Misuno K, Guo M, Huang Z, Chen X, Hu S. Sox11 promotes head and neck cancer progression via the regulation of SDCCAG8. J Exp Clin Cancer Res 2019;38:138. [PMID: 30922366 DOI: 10.1186/s13046-019-1146-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
25 Tamilzhalagan S, Muthuswami M, Ganesan K. Juxtaposed genes in 7q21-22 amplicon contribute for two major gastric cancer sub-Types by mutual exclusive expression: MUTUAL EXCLUSIVE EXPRESSION AMONG 7q21-22 GENES. Mol Carcinog 2017;56:1239-50. [DOI: 10.1002/mc.22586] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
26 Li J, Jin H, Wang X. Epigenetic biomarkers: potential applications in gastrointestinal cancers. ISRN Gastroenterol. 2014;2014:464015. [PMID: 24729878 DOI: 10.1155/2014/464015] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
27 Moreira AM, Pereira J, Melo S, Fernandes MS, Carneiro P, Seruca R, Figueiredo J. The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression. Cells 2020;9:E394. [PMID: 32046329 DOI: 10.3390/cells9020394] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
28 Wu H, Rusiecki JA, Zhu K, Potter J, Devesa SS. Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site. Cancer Epidemiol Biomarkers Prev. 2009;18:1945-1952. [PMID: 19531677 DOI: 10.1158/1055-9965.epi-09-0250] [Cited by in Crossref: 120] [Cited by in F6Publishing: 66] [Article Influence: 9.2] [Reference Citation Analysis]
29 Yin Y, Zhuo W, Zhao Y, Chen S, Li J, Wang L, Zhou T, Si JM. Converting a microarray signature into a diagnostic test: a trial of custom 74 gene array for clarification and prediction the prognosis of gastric cancer. PLoS One 2013;8:e81561. [PMID: 24312559 DOI: 10.1371/journal.pone.0081561] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
30 Min L, Zhao Y, Zhu S, Qiu X, Cheng R, Xing J, Shao L, Guo S, Zhang S. Integrated Analysis Identifies Molecular Signatures and Specific Prognostic Factors for Different Gastric Cancer Subtypes. Transl Oncol 2017;10:99-107. [PMID: 28013168 DOI: 10.1016/j.tranon.2016.11.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
31 Gologan A, Graham DY, Sepulveda AR. Molecular markers in Helicobacter pylori-associated gastric carcinogenesis. Clin Lab Med. 2005;25:197-222. [PMID: 15749238 DOI: 10.1016/j.cll.2004.12.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
32 Lin SC, Chen WY, Lin KY, Chen SH, Chang CC, Lin SE, Fang CL. Clinicopathological correlation and prognostic significance of protein kinase cα overexpression in human gastric carcinoma. PLoS One 2013;8:e56675. [PMID: 23468872 DOI: 10.1371/journal.pone.0056675] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
33 Ling Z, Sugihara H, Tatsuta T, Mukaisho K, Hattori T. Optimization of comparative expressed sequence hybridization for genome-wide expression profiling at chromosome level. Cancer Genetics and Cytogenetics 2007;175:144-53. [DOI: 10.1016/j.cancergencyto.2007.02.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 LArki P, Ahadi A, Zare A, Tarighi S, Zaheri M, Souri M, Zali MR, Ghaedi H, Omrani MD. Up-Regulation of miR-21, miR-25, miR-93, and miR-106b in Gastric Cancer. Iran Biomed J 2018;22:367-73. [PMID: 29859516 [PMID: 29859516 DOI: 10.29252/.22.6.367] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
35 Yamaguchi H, Takanashi M, Yoshida N, Ito Y, Kamata R, Fukami K, Yanagihara K, Sakai R. Saracatinib impairs the peritoneal dissemination of diffuse-type gastric carcinoma cells resistant to Met and fibroblast growth factor receptor inhibitors. Cancer Sci 2014;105:528-36. [PMID: 24612061 DOI: 10.1111/cas.12387] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
36 Yang HK. Operating room to bench for gastric cancer. Pathobiology 2011;78:320-7. [PMID: 22104203 DOI: 10.1159/000331225] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
37 Zhen H, Yang S, Wu H, Wang S, Lv J, Ma L, Zhang X. LyGDI is a Promising Biomarker for Ovarian Cancer: . International Journal of Gynecological Cancer 2010;20:316-22. [DOI: 10.1111/igc.0b013e3181d0b02d] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Aburatani H. Discovery of a new biomarker for gastroenterological cancers. J Gastroenterol 2005;40:1-6. [DOI: 10.1007/bf02990571] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
39 Förster S, Gretschel S, Jöns T, Yashiro M, Kemmner W. THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol. 2011;24:1390-1403. [PMID: 21701537 DOI: 10.1038/modpathol.2011.99] [Cited by in Crossref: 66] [Cited by in F6Publishing: 64] [Article Influence: 6.0] [Reference Citation Analysis]
40 Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y, Kaminishi M, Calin GA, Croce CM. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2010;11:136-46. [PMID: 20022810 DOI: 10.1016/S1470-2045(09)70343-2] [Cited by in Crossref: 567] [Cited by in F6Publishing: 381] [Article Influence: 43.6] [Reference Citation Analysis]
41 Tamilzhalagan S, Rathinam D, Ganesan K. Amplified 7q21-22 gene MCM7 and its intronic miR-25 suppress COL1A2 associated genes to sustain intestinal gastric cancer features. Mol Carcinog 2017;56:1590-602. [DOI: 10.1002/mc.22614] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
42 Cetin B, Gumusay O, Cengiz M, Ozet A. Advances of Molecular Targeted Therapy in Gastric Cancer. J Gastrointest Canc 2016;47:125-34. [DOI: 10.1007/s12029-016-9806-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
43 Naito Y, Mizushima K, Yoshikawa T. Global Analysis of Gene Expression in Gastric Ischemia-Reperfusion: A Future Therapeutic Direction for Mucosal Protective Drugs. Dig Dis Sci 2005;50:S45-55. [DOI: 10.1007/s10620-005-2806-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
44 Yin Y, Zhao Y, Li A, Si J. Collagen: A possible prediction mark for gastric cancer. Medical Hypotheses 2009;72:163-5. [DOI: 10.1016/j.mehy.2008.09.010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
45 Yang B, Luo T, Zhang M, Lu Z, Xue X, Fang G. The novel long noncoding RNA RP11-357H14.17 acts as an oncogene by promoting cell proliferation and invasion in diffuse-type gastric cancer. Onco Targets Ther. 2017;10:2635-2643. [PMID: 28572735 DOI: 10.2147/ott.s134121] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
46 Otsuka Y, Ichikawa Y, Kunisaki C, Matsuda G, Akiyama H, Nomura M, Togo S, Hayashizaki Y, Shimada H. Correlating purity by microdissection with gene expression in gastric cancer tissue. Scand J Clin Lab Invest 2007;67:367-79. [PMID: 17558891 DOI: 10.1080/00365510601046334] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
47 Liu R, Zhang C, Hu Z, Li G, Wang C, Yang C, Huang D, Chen X, Zhang H, Zhuang R. A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur J Cancer. 2011;47:784-791. [PMID: 21112772 DOI: 10.1016/j.ejca.2010.10.025] [Cited by in Crossref: 298] [Cited by in F6Publishing: 288] [Article Influence: 24.8] [Reference Citation Analysis]
48 Wang G, Hu N, Yang HH, Wang L, Su H, Wang C, Clifford R, Dawsey EM, Li JM, Ding T. Comparison of global gene expression of gastric cardia and noncardia cancers from a high-risk population in china. PLoS One. 2013;8:e63826. [PMID: 23717493 DOI: 10.1371/journal.pone.0063826] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 6.2] [Reference Citation Analysis]
49 Mai C, Zhao JJ, Tang XF, Wang W, Pan K, Pan QZ, Zhang XF, Jiang SS, Zhao BW, Li YF. Decreased ITIH5 expression is associated with poor prognosis in primary gastric cancer. Med Oncol. 2014;31:53. [PMID: 24913813 DOI: 10.1007/s12032-014-0053-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
50 Zhang C, Min L, Liu J, Tian W, Han Y, Qu L, Shou C. Integrated analysis identified an intestinal-like and a diffuse-like gene sets that predict gastric cancer outcome. Tumour Biol 2016. [PMID: 27858295 DOI: 10.1007/s13277-016-5454-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
51 Jinawath N, Shiao MS, Chanpanitkitchote P, Svasti J, Furukawa Y, Nakamura Y. Enhancement of Migration and Invasion of Gastric Cancer Cells by IQGAP3. Biomolecules 2020;10:E1194. [PMID: 32824461 DOI: 10.3390/biom10081194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
52 Sandy Z, da Costa IC, Schmidt CK. More than Meets the ISG15: Emerging Roles in the DNA Damage Response and Beyond. Biomolecules 2020;10:E1557. [PMID: 33203188 DOI: 10.3390/biom10111557] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Itadani H, Oshima H, Oshima M, Kotani H. Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer. BMC Genomics 2009;10:615. [PMID: 20015407 DOI: 10.1186/1471-2164-10-615] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
54 Lin J, Zhou T, Wang J. Solution structure of the human HSPC280 protein. Protein Sci 2011;20:216-23. [PMID: 21082705 DOI: 10.1002/pro.548] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
55 Hudler P, Repše S, Juvan R, Komel R. A genomic approach to investigate expression profiles in Slovenian patients with gastric cancer. Oncol Lett. 2011;2:1003-1014. [PMID: 22866164 DOI: 10.3892/ol.2011.362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
56 Holmes K, Egan B, Swan N, O'Morain C. Genetic Mechanisms and Aberrant Gene Expression during the Development of Gastric Intestinal Metaplasia and Adenocarcinoma. Curr Genomics. 2007;8:379-397. [PMID: 19412438 DOI: 10.2174/138920207783406460] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
57 Kim BC, Jeong HO, Park D, Kim CH, Lee EK, Kim DH, Im E, Kim ND, Lee S, Yu BP, Bhak J, Chung HY. Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects. Cancer Inform 2015;14:47-54. [PMID: 25983541 DOI: 10.4137/CIN.S16912] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
58 Lee IS, Ahn J, Kim K, Okugawa Y, Toiyama Y, Hur H, Goel A. A blood-based transcriptomic signature for noninvasive diagnosis of gastric cancer. Br J Cancer 2021. [PMID: 34163003 DOI: 10.1038/s41416-021-01461-3] [Reference Citation Analysis]
59 Sarvepalli S, Garg SK, Sarvepalli SS, Anugwom C, Wadhwa V, Thota PN, Sanaka MR. Hospital Utilization in Patients With Gastric Cancer and Factors Affecting In-Hospital Mortality, Length of Stay, and Costs. J Clin Gastroenterol 2019;53:e157-63. [PMID: 29517707 DOI: 10.1097/MCG.0000000000001016] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
60 Kim TW, Lee SJ, Oh BM, Lee H, Uhm TG, Min JK, Park YJ, Yoon SR, Kim BY, Kim JW. Epigenetic modification of TLR4 promotes activation of NF-κB by regulating methyl-CpG-binding domain protein 2 and Sp1 in gastric cancer. Oncotarget. 2015; Dec 10. [Epub ahead of print]. [PMID: 26675260 DOI: 10.18632/oncotarget.6549] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 4.8] [Reference Citation Analysis]
61 Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K. CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene. 2008;27:1562-1571. [PMID: 17873905 DOI: 10.1038/sj.onc.1210799] [Cited by in Crossref: 121] [Cited by in F6Publishing: 128] [Article Influence: 8.1] [Reference Citation Analysis]
62 Tsuboi S, Taketa K, Nouso K, Fujikawa T, Manabe K, Ohmori H, Higashi T, Shiratori Y. High level of expression of alpha-fetoprotein receptor in gastric cancers. Tumour Biol 2006;27:283-8. [PMID: 17028464 DOI: 10.1159/000096071] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
63 Kim H, Eun JW, Lee H, Nam SW, Rhee H, Koh KH, Kim H. Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas. Exp Mol Pathol 2011;90:201-9. [PMID: 21185829 DOI: 10.1016/j.yexmp.2010.12.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
64 Gallo A, Ronzio M, Bezzecchi E, Mantovani R, Dolfini D. NF-Y subunits overexpression in gastric adenocarcinomas (STAD). Sci Rep 2021;11:23764. [PMID: 34887475 DOI: 10.1038/s41598-021-03027-y] [Reference Citation Analysis]
65 Tan IB, Ivanova T, Lim KH, Ong CW, Deng N, Lee J, Tan SH, Wu J, Lee MH, Ooi CH, Rha SY, Wong WK, Boussioutas A, Yeoh KG, So J, Yong WP, Tsuburaya A, Grabsch H, Toh HC, Rozen S, Cheong JH, Noh SH, Wan WK, Ajani JA, Lee JS, Tellez MS, Tan P. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology 2011;141:476-85, 485.e1-11. [PMID: 21684283 DOI: 10.1053/j.gastro.2011.04.042] [Cited by in Crossref: 209] [Cited by in F6Publishing: 209] [Article Influence: 19.0] [Reference Citation Analysis]
66 Yuge R, Kitadai Y, Takigawa H, Naito T, Oue N, Yasui W, Tanaka S, Chayama K. Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer. Transl Oncol 2018;11:575-84. [PMID: 29547756 DOI: 10.1016/j.tranon.2018.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
67 Cheng L, Wang P, Yang S, Yang Y, Zhang Q, Zhang W, Xiao H, Gao H, Zhang Q. Identification of genes with a correlation between copy number and expression in gastric cancer. BMC Med Genomics. 2012;5:14. [PMID: 22559327 DOI: 10.1186/1755-8794-5-14] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 6.1] [Reference Citation Analysis]
68 Konno-Shimizu M, Yamamichi N, Inada K, Kageyama-Yahara N, Shiogama K, Takahashi Y, Asada-Hirayama I, Yamamichi-Nishina M, Nakayama C, Ono S, Kodashima S, Fujishiro M, Tsutsumi Y, Ichinose M, Koike K. Cathepsin E is a marker of gastric differentiation and signet-ring cell carcinoma of stomach: a novel suggestion on gastric tumorigenesis. PLoS One 2013;8:e56766. [PMID: 23451082 DOI: 10.1371/journal.pone.0056766] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.8] [Reference Citation Analysis]
69 Ureshino H, Murakami Y, Watari K, Izumi H, Kawahara A, Kage M, Arao T, Nishio K, Yanagihara K, Kinoshita H, Kuwano M, Ono M. N-myc downstream regulated gene 1 (NDRG1) promotes metastasis of human scirrhous gastric cancer cells through epithelial mesenchymal transition. PLoS One 2012;7:e41312. [PMID: 22844455 DOI: 10.1371/journal.pone.0041312] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.5] [Reference Citation Analysis]
70 Zuo C, Sheng X, Ma M, Xia M, Ouyang L. ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system. Oncotarget 2016;7:74393-409. [PMID: 27626310 DOI: 10.18632/oncotarget.11911] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
71 Nakamura Y, Migita T, Hosoda F, Okada N, Gotoh M, Arai Y, Fukushima M, Ohki M, Miyata S, Takeuchi K, Imoto I, Katai H, Yamaguchi T, Inazawa J, Hirohashi S, Ishikawa Y, Shibata T. Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression. Int J Cancer 2009;125:1859-67. [PMID: 19588488 DOI: 10.1002/ijc.24538] [Cited by in Crossref: 51] [Cited by in F6Publishing: 49] [Article Influence: 3.9] [Reference Citation Analysis]
72 Antonov AV, Dietmann S, Mewes HW. KEGG spider: interpretation of genomics data in the context of the global gene metabolic network. Genome Biol 2008;9:R179. [PMID: 19094223 DOI: 10.1186/gb-2008-9-12-r179] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 3.8] [Reference Citation Analysis]
73 Kim HK, Kim J, Korolevich S, Choi IJ, Kim CH, Munroe DJ, Green JE. Distinctions in gastric cancer gene expression signatures derived from laser capture microdissection versus histologic macrodissection. BMC Med Genomics 2011;4:48. [PMID: 21635755 DOI: 10.1186/1755-8794-4-48] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
74 Wu MS, Lin YS, Chang YT, Shun CT, Lin MT, Lin JT. Gene expression profiling of gastric cancer by microarray combined with laser capture microdissection. World J Gastroenterol 2005;11:7405-12. [PMID: 16437709 DOI: 10.3748/wjg.v11.i47.7405] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
75 Tomioka N, Morita K, Kobayashi N, Tada M, Itoh T, Saitoh S, Kondo M, Takahashi N, Kataoka A, Nakanishi K. Array comparative genomic hybridization analysis revealed four genomic prognostic biomarkers for primary gastric cancers. Cancer Genet Cytogenet. 2010;201:6-14. [PMID: 20633762 DOI: 10.1016/j.cancergencyto.2010.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
76 Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol. 2010;11:136-146. [PMID: 20022810 DOI: 10.1016/s1470-2045(13)70464-9] [Cited by in Crossref: 169] [Cited by in F6Publishing: 65] [Article Influence: 13.0] [Reference Citation Analysis]
77 Nagaraju GP, Kasa P, Dariya B, Surepalli N, Peela S, Ahmad S. Epigenetics and therapeutic targets in gastrointestinal malignancies. Drug Discov Today 2021:S1359-6446(21)00202-6. [PMID: 33895313 DOI: 10.1016/j.drudis.2021.04.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Zhang T, Liu C, Huang S, Ma Y, Fang J, Chen Y. A Downmodulated MicroRNA Profiling in Patients with Gastric Cancer. Gastroenterol Res Pract 2017;2017:1526981. [PMID: 28546810 DOI: 10.1155/2017/1526981] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
79 Harao M, Hirata S, Irie A, Senju S, Nakatsura T, Komori H, Ikuta Y, Yokomine K, Imai K, Inoue M, Harada K, Mori T, Tsunoda T, Nakatsuru S, Daigo Y, Nomori H, Nakamura Y, Baba H, Nishimura Y. HLA-A2-restricted CTL epitopes of a novel lung cancer-associated cancer testis antigen, cell division cycle associated 1, can induce tumor-reactive CTL. Int J Cancer 2008;123:2616-25. [DOI: 10.1002/ijc.23823] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 4.1] [Reference Citation Analysis]
80 Shimamura T, Ito H, Shibahara J, Watanabe A, Hippo Y, Taniguchi H, Chen Y, Kashima T, Ohtomo T, Tanioka F. Overexpression of MUC13 is associated with intestinal-type gastric cancer. Cancer Sci. 2005;96:265-273. [PMID: 15904467 DOI: 10.1111/j.1349-7006.2005.00043.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
81 Inoue M, Senju S, Hirata S, Ikuta Y, Hayashida Y, Irie A, Harao M, Imai K, Tomita Y, Tsunoda T, Furukawa Y, Ito T, Nakamura Y, Baba H, Nishimura Y. Identification of SPARC as a candidate target antigen for immunotherapy of various cancers. Int J Cancer. 2010;127:1393-1403. [PMID: 20063317 DOI: 10.1002/ijc.25160] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.8] [Reference Citation Analysis]
82 Cheng TY, Wu MS, Lin JT, Lin MT, Shun CT, Huang HY, Hua KT, Kuo ML. Annexin A1 is associated with gastric cancer survival and promotes gastric cancer cell invasiveness through the formyl peptide receptor/extracellular signal-regulated kinase/integrin beta-1-binding protein 1 pathway. Cancer. 2012;118:5757-5767. [PMID: 22736399 DOI: 10.1002/cncr.27565] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.2] [Reference Citation Analysis]